Search Results

There are 10826 results for: content related to: Characterization of molecular and cellular functions of the cyclin-dependent kinase CDK9 using a novel specific inhibitor

  1. You have free access to this content
    Differential interactions of antiretroviral agents with LXR, ER and GR nuclear receptors: potential contributing factors to adverse events

    British Journal of Pharmacology

    Volume 171, Issue 2, January 2014, Pages: 480–497, J Svärd, F Blanco, D Nevin, D Fayne, F Mulcahy, M Hennessy and J P Spiers

    Version of Record online : 23 DEC 2013, DOI: 10.1111/bph.12480

  2. You have free access to this content
    Flavopiridol inhibits lipopolysaccharide-induced TNF-α production through inactivation of nuclear factor-κB and mitogen-activated protein kinases in the MyD88-dependent pathway

    Microbiology and Immunology

    Volume 55, Issue 3, March 2011, Pages: 160–167, Abedul Haque, Naoki Koide, Imtiaz Iftakhar-E-Khuda, Abu Shadat Mohammod Noman, Erdenezaya Odkhuu, Battuvshin Badamtseren, Yoshikazu Naiki, Takayuki Komatsu, Tomoaki Yoshida and Takashi Yokochi

    Version of Record online : 23 FEB 2011, DOI: 10.1111/j.1348-0421.2010.00304.x

  3. Investigation of the cytotoxic effect of flavopiridol in canine lymphoma cell lines

    Veterinary and Comparative Oncology

    Y. Ema, M. Igase, Y. Takeda, T. Yanase, S. Umeki, H. Hiraoka, M. Okuda and T. Mizuno

    Version of Record online : 26 JAN 2015, DOI: 10.1111/vco.12130

  4. Flavopiridol as a radio-sensitizer for esophageal cancer cell lines

    Diseases of the Esophagus

    Volume 17, Issue 4, December 2004, Pages: 338–344, S. Sato, Y. Kajiyama, M. Sugano, Y. Iwanuma and M. Tsurumaru

    Version of Record online : 24 NOV 2004, DOI: 10.1111/j.1442-2050.2004.00437.x

  5. You have free access to this content
    Reduced occurrence of tumor flare with flavopiridol followed by combined flavopiridol and lenalidomide in patients with relapsed chronic lymphocytic leukemia (CLL)

    American Journal of Hematology

    Volume 90, Issue 4, April 2015, Pages: 327–333, Kami Maddocks, Lai Wei, Darlene Rozewski, Yao Jiang, Yuan Zhao, Mikhil Adusumilli, William E. Pierceall, Camille Doykin, Michael H. Cardone, Jeffrey A. Jones, Joseph Flynn, Leslie A. Andritsos, Michael R. Grever, John C. Byrd, Amy J. Johnson, Mitch A. Phelps and Kristie A Blum

    Version of Record online : 25 FEB 2015, DOI: 10.1002/ajh.23946

  6. You have free access to this content
    Cell cycle-independent induction of apoptosis by the anti-tumor drug flavopiridol in endothelial cells

    International Journal of Cancer

    Volume 77, Issue 1, 3 July 1998, Pages: 146–152, Sabine Brüsselbach, Dirk M. Nettelbeck, Hans-Harald Sedlacek and Rolf Müller

    Version of Record online : 6 DEC 1998, DOI: 10.1002/(SICI)1097-0215(19980703)77:1<146::AID-IJC22>3.0.CO;2-B

  7. You have free access to this content
    CDKI-71, a novel CDK9 inhibitor, is preferentially cytotoxic to cancer cells compared to flavopiridol

    International Journal of Cancer

    Volume 130, Issue 5, 1 March 2012, Pages: 1216–1226, Xiangrui Liu, Shenhua Shi, Frankie Lam, Chris Pepper, Peter M. Fischer and Shudong Wang

    Version of Record online : 21 JUN 2011, DOI: 10.1002/ijc.26127

  8. You have free access to this content
    Identification of cytosolic aldehyde dehydrogenase 1 from non-small cell lung carcinomas as a flavopiridol-binding protein

    FEBS Letters

    Volume 454, Issue 1-2, July 02, 1999, Pages: 100–104, Joachim B. Schnier, Gurmet Kaur, Astrid Kaiser, Sherman F. Stinson, Edward A. Sausville, John Gardner, Kayoko Nishi, E.Morton Bradbury and Adrian M. Senderowicz

    Version of Record online : 6 JUL 1999, DOI: 10.1016/S0014-5793(99)00773-5

  9. Preclinical study of treatment response in HCT-116 cells and xenografts with 1H-decoupled 31P MRS

    NMR in Biomedicine

    Volume 24, Issue 9, November 2011, Pages: 1159–1168, Moses M. Darpolor, Peter T. Kennealey, H. Carl Le, Kristen L. Zakian, Ellen Ackerstaff, Asif Rizwan, Jin-Hong Chen, Elliot B. Sambol, Gary K. Schwartz, Samuel Singer and Jason A. Koutcher

    Version of Record online : 24 MAR 2011, DOI: 10.1002/nbm.1674

  10. You have free access to this content
    Delayed combinatorial treatment with flavopiridol and minocycline provides longer term protection for neuronal soma but not dendrites following global ischemia

    Journal of Neurochemistry

    Volume 105, Issue 3, May 2008, Pages: 703–713, Grace O. Iyirhiaro, Tyson B. Brust, Juliet Rashidian, Zohreh Galehdar, Aweis Osman, Maryam Phillips, Ruth S. Slack, Brian A. MacVicar and David S. Park

    Version of Record online : 6 DEC 2007, DOI: 10.1111/j.1471-4159.2007.05166.x

  11. You have free access to this content
    Cyclin-dependent kinase inhibitor, flavopiridol, induces apoptosis and inhibits tumor growth in drug-resistant osteosarcoma and Ewing's family tumor cells

    International Journal of Cancer

    Volume 121, Issue 6, 15 September 2007, Pages: 1212–1218, Yan Li, Kazuhiro Tanaka, Xu Li, Takamitsu Okada, Tomoyuki Nakamura, Minoru Takasaki, Shunsaku Yamamoto, Yoshinao Oda, Masazumi Tsuneyoshi and Yukihide Iwamoto

    Version of Record online : 22 MAY 2007, DOI: 10.1002/ijc.22820

  12. Identification of Flavopiridol Analogues that Selectively Inhibit Positive Transcription Elongation Factor (P-TEFb) and Block HIV-1 Replication

    ChemBioChem

    Volume 10, Issue 12, August 17, 2009, Pages: 2072–2080, Akbar Ali, Animesh Ghosh, Robin S. Nathans, Natalia Sharova, Siobhan O'Brien, Hong Cao, Mario Stevenson and Tariq M. Rana

    Version of Record online : 14 JUL 2009, DOI: 10.1002/cbic.200900303

  13. You have free access to this content
    The structure of P-TEFb (CDK9/cyclin T1), its complex with flavopiridol and regulation by phosphorylation

    The EMBO Journal

    Volume 27, Issue 13, July 9, 2008, Pages: 1907–1918, Sonja Baumli, Graziano Lolli, Edward D Lowe, Sonia Troiani, Luisa Rusconi, Alex N Bullock, Judit É Debreczeni, Stefan Knapp and Louise N Johnson

    Version of Record online : 19 JUN 2008, DOI: 10.1038/emboj.2008.121

  14. You have free access to this content
    Transactivation of cyclin E gene by EWS-Fli1 and antitumor effects of cyclin dependent kinase inhibitor on Ewing's family tumor cells

    International Journal of Cancer

    Volume 116, Issue 3, 1 September 2005, Pages: 385–394, Xu Li, Kazuhiro Tanaka, Fumihiko Nakatani, Tomoya Matsunobu, Riku Sakimura, Masuo Hanada, Takamitsu Okada, Tomoyuki Nakamura and Yukihide Iwamoto

    Version of Record online : 7 APR 2005, DOI: 10.1002/ijc.21010

  15. Efficacy of sequential treatment of HCT116 colon cancer monolayers and xenografts with docetaxel, flavopiridol, and 5-fluorouracil

    Acta Pharmacologica Sinica

    Volume 27, Issue 10, October 2006, Pages: 1375–1381, Jun GUO, An-wu ZHOU, Yu-cai FU, Udit N VERMA, Debu TRIPATHY, Eugene PFRENKEL and Carlos R BECERRA

    Version of Record online : 11 OCT 2006, DOI: 10.1111/j.1745-7254.2006.00421.x

  16. Sequential combinations of flavopiridol and docetaxel inhibit prostate tumors, induce apoptosis, and decrease angiogenesis in the Gγ/T-15 transgenic mouse model of prostate cancer

    The Prostate

    Volume 66, Issue 14, 1 October 2006, Pages: 1487–1497, Teresita Reiner, Alicia de las Pozas and Carlos Perez-Stable

    Version of Record online : 18 AUG 2006, DOI: 10.1002/pros.20478

  17. You have free access to this content
    Cyclin-Dependent Kinase 9 Inhibition Protects Cartilage From the Catabolic Effects of Proinflammatory Cytokines

    Arthritis & Rheumatology

    Volume 66, Issue 6, June 2014, Pages: 1537–1546, Jasper H. N. Yik, Zi'ang Hu, Ratna Kumari, Blaine A. Christiansen and Dominik R. Haudenschild

    Version of Record online : 27 MAY 2014, DOI: 10.1002/art.38378

  18. A high-performance liquid chromatography method using ultraviolet detection for the quantitation of flavopiridol from human plasma

    Biomedical Chromatography

    Volume 16, Issue 6, September 2002, Pages: 379–382, Suoping Zhai, Edward Sausville and William D. Figg

    Version of Record online : 10 APR 2002, DOI: 10.1002/bmc.166

  19. Inhibition of CDKs as a Therapeutic Modality

    Annals of the New York Academy of Sciences

    Volume 910, Issue 1, June 2000, Pages: 207–222, EDWARD A. SAUSVILLE, JILL JOHNSON, MICHAEL ALLEY, DANIEL ZAHAREVITZ and ADRIAN M. SENDEROWICZ

    Version of Record online : 25 JAN 2006, DOI: 10.1111/j.1749-6632.2000.tb06710.x

  20. T-loop phosphorylated Cdk9 localizes to nuclear speckle domains which may serve as sites of active P-TEFb function and exchange between the Brd4 and 7SK/HEXIM1 regulatory complexes

    Journal of Cellular Physiology

    Volume 224, Issue 1, July 2010, Pages: 84–93, Eugene C. Dow, Hongbing Liu and Andrew P. Rice

    Version of Record online : 3 MAR 2010, DOI: 10.1002/jcp.22096